Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.62 |
| ▸ | MEN1 | O00255 | 4/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.62 |
| ▸ | HPGD | P15428 | 4/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 5/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | CES1 | P23141 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5932634 | 0.82 | HPGD (0.68) | ALDH1A1CYP3A4MEN1KMT2AHPGD | |
| SCHEMBL6505370 | 0.82 | ALDH1A1 (0.61) | ALDH1A1CYP3A4MEN1KMT2AHPGD | |
| SCHEMBL8611106 | 0.81 | KMT2A (0.50) | ALDH1A1CYP3A4MEN1KMT2AHPGD | |
| Bromide SCHEMBL10777716 | 0.80 | HPGD (0.65) | ALDH1A1CYP3A4MEN1KMT2AHPGD | |
| Hydrochloric Acid SCHEMBL9432569 | 0.80 | HPGD (0.65) | ALDH1A1CYP3A4MEN1KMT2AHPGD | |
| SCHEMBL23014514 | 0.80 | GSK3B (0.53) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| SCHEMBL3846983 | 0.80 | MAPT (0.58) | ALDH1A1CYP3A4MEN1KMT2AHPGD | |
| SCHEMBL9980337 | 0.80 | ALDH1A1 (0.58) | ALDH1A1CYP3A4MEN1KMT2AHPGD | |
| SCHEMBL6005005 | 0.80 | TDP1 (0.54) | ALDH1A1CYP3A4MEN1KMT2AHPGD | |
| SCHEMBL26114568 | 0.80 | KMT2A (0.53) | ALDH1A1CYP3A4MEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970307-B1 | PYRAZOLO COMPOUNDS AND USES THEREOF | GENENTECH INC (US) | 2020-03-11 | — | — | EP | claimed |
| US-10035801-B2 | Pyrazolo compounds and uses thereof | GENENTECH, INC. (US) | 2018-07-31 | — | — | US | claimed |
| US-20160060267-A1 | PYRAZOLO COMPOUNDS AND USES THEREOF | GENENTECH, INC. (US) | 2016-03-03 | — | — | US | claimed |
| EP-2970307-A1 | PYRAZOLO COMPOUNDS AND USES THEREOF | Genentech, Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014139326-A1 | PYRAZOLO COMPOUNDS AND USES THEREOF | GENENTECH, INC. (US) | 2014-09-18 | — | — | WO | claimed |
| US-6403633-B2 | USEFUL ANTIANGIOGENIC, ANTIARTHRITIC, ANTIINFLAMMATORY, ANTIRESTENOTIC, ANTIINVASIVE, ANTIMETASTIC, ANTIOSTEOPOROTIC, ANTIRETINOPATHIC, CONTRACEPTIVE AND TUMORISTATIC TREATMENT AGENTS | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2002-06-11 | — | — | US | claimed |
| US-11814385-B2 | Small molecule inhibitors targeting Clostridioides difficile sporulation | UNIVERSITY OF SOUTH FLORIDA (US) | 2023-11-14 | — | — | US | disclosed |
| US-11814385-B2 | Small molecule inhibitors targeting Clostridioides difficile sporulation | UNIVERSITY OF SOUTH FLORIDA (US) | 2023-11-14 | — | — | US | disclosed |
| US-20230002381-A1 | SMALL MOLECULE INHIBITORS TARGETING CLOSTRIDIOIDES DIFFICILE SPORULATION | NATIONAL INSTITUTES OF HEALTH | 2023-01-05 | — | — | US | disclosed |
| US-20220202792-A1 | METHODS AND COMPOSITIONS FOR TREATING CHRONIC INFLAMMATORY INJURY, METAPLASIA, DYSPLASIA AND CANCERS OF EPITHELIAL TISSUES | UNIVERSITY OF HOUSTON SYSTEM (US) | 2022-06-30 | — | — | US | disclosed |
| EP-3962559-A1 | METHODS AND COMPOSITIONS FOR TREATING CHRONIC INFLAMMATORY INJURY, METAPLASIA, DYSPLASIA AND CANCERS OF EPITHELIAL TISSUES | University of Houston System (US) | 2022-03-09 | — | — | EP | disclosed |
| WO-2021034087-A1 | NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND | 주식회사 셀젠텍 | 2021-02-25 | — | — | WO | disclosed |
| WO-2020219963-A1 | METHODS AND COMPOSITIONS FOR TREATING CHRONIC INFLAMMATORY INJURY, METAPLASIA, DYSPLASIA AND CANCERS OF EPITHELIAL TISSUES | UNIVERSITY OF HOUSTON SYSTEM (US) | 2020-10-29 | — | — | WO | disclosed |
| US-6448028-B1 | METHODS TO IDENTIFY AND REDUCE BOAR TAINT, DUE TO HIGH LEVELS OF EITHER THE 16-ANDROSTENE STEROIDS OR SKATOLE IN FAT, BY MEASURING LEVELS OF METABOLITES | UNIVERSITY OF GUELPH (CA) | 2002-09-10 | — | — | US | disclosed |
| EP-1218534-A2 | NOVEL ENZYMES AND METABOLITES INVOLVED IN SKATOLE METABOLISM | University of Guelph (CA) | 2002-07-03 | — | — | EP | disclosed |
| EP-1207161-A1 | NOVEL ISOINDOLE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2002-05-22 | — | — | EP | disclosed |
| WO-2002036116-A2 | TRIPEPTIDYL PEPTIDASE INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2002-05-10 | — | — | WO | disclosed |
| WO-2001023601-A2 | NOVEL ENZYMES AND METABOLITES INVOLVED IN SKATOLE METABOLISM | UNIVERSITY OF GUELPH (CA) | 2001-04-05 | — | — | WO | disclosed |
| WO-2000073288-A1 | METHOD FOR PREPARING 5-SUBSTITUTED OXAZOLES | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2000-12-07 | — | — | WO | disclosed |
| EP-0114758-B1 | +/- 2-((3,4-METHYLENEDIOXY)PHENETHYL)-5-((3-CARBOXAMIDO-4-HYDROXY)-ALPHA-HYDROXYBENZYL)PYRROLIDINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PROCESS FOR THEIR PRODUCTION AND INTERMEDIATES THEREFOR | SYNTEX (U.S.A.) INC. (US) | 1986-11-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10035801-B2 | Pyrazolo compounds and uses thereof | KDM5A, KDM5C, KDM5B | ALDH1A1 1424/4885CYP3A4 1461/4885MEN1 2686/4885 |
| US-20230002381-A1 | SMALL MOLECULE INHIBITORS TARGETING CLOSTRIDIOIDES DIFFICILE SPORULATION | SPOUT1, CLPP, RPN2 | ALDH1A1 2083/4885CYP3A4 2042/4885MEN1 4676/4885 |
| US-20160060267-A1 | PYRAZOLO COMPOUNDS AND USES THEREOF | KDM5A, KDM5C, KDM5B | ALDH1A1 1424/4885CYP3A4 1461/4885MEN1 2686/4885 |
| US-20220202792-A1 | METHODS AND COMPOSITIONS FOR TREATING CHRONIC INFLAMMATORY INJURY, METAPLASIA, DYSPLASIA AND CANCERS OF EPITHELIAL TISSUES | FABP2, MUC1, FABP6 | ALDH1A1 76/4885CYP3A4 4552/4885MEN1 3526/4885 |
| US-11814385-B2 | Small molecule inhibitors targeting Clostridioides difficile sporulation | SPOUT1, CLPP, RPN2 | ALDH1A1 2083/4885CYP3A4 2042/4885MEN1 4676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.